Join to View Full Profile
450 Brookline AveBoston, MA 02215
Phone+1 617-632-3000
Dr. Aguilar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ana Aguilar is a Pediatric Neuro-Oncologist at Dana-Farber/Boston Children’s Hospital. She received her MD from Universidad Evangélica de El Salvador, completed her Pediatrics residency at SUNY Downstate, a Hematology-Oncology fellowship at Oakland Children’s Hospital, and Neuro-Oncology training at Children’s Hospital Los Angeles.
Education & Training
Children's Hospital of Los AngelesPost-Doctoral Fellowship, Pediatric Neuro-Oncology, 2014 - 2015
UCSF Benioff Children's Hospital OaklandPost-Doctoral Fellowship, 2013 - 2014- UCSF Benioff Children’s Hospital OaklandFellowship, Pediatric Hematology/Oncology, 2010 - 2013
SUNY Downstate Health Sciences UniversityResidency, Pediatrics, 2007 - 2010
University Evangelica, Fac De MedClass of 2004
Certifications & Licensure
CA State Medical License 2010 - Present
FL State Medical License 2015 - 2027
MA State Medical License 2024 - 2026
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 2 citationsReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.Christopher L Moertel, Angela C Hirbe, Hans H Shuhaiber, Kevin Bielamowicz, Alpa Sidhu
Journal of Clinical Oncology. 2025-02-20 - Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.Audrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, Elke Pfaff, Pouneh Amir-Yazdani
Clinical Cancer Research. 2025-02-03 - Fibroblast growth factor receptor 1 gene mutation as a potential risk factor for spontaneous intracranial hemorrhage in pediatric low-grade glioma patients.Maxine Gonzalez-Vega, Brittany M Lebert, Stephani Campion, Aaron Wagner, Ana Aguilar-Bonilla
Neuro-Oncology Advances. 2024-06-04
Press Mentions
Photos: The Reality of the Current Coronavirus SurgeDecember 2nd, 2020- Employers Require COVID Liability Waivers as Conflict Mounts over Workplace SafetyJuly 27th, 2020
- Summaries of Health Policy Coverage from Major News OrganizationsJuly 27th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
